Suchergebnisse - "Vaduganathan, Muthiah"

PubPharm (251)

1

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : The DELIVER Trial

enthalten in: Circulation | 2023

von Ostrominski, J. | Vaduganathan, M. | Selvaraj, S. | +15

2

Efficacy of Dapagliflozin According to Heart Rate : A Patient-Level Pooled Analysis of DAPA-HF and DELIVER

enthalten in: Circulation. Heart failure | 2023

von Kondo, T. | Butt, J. | Curtain, J. | +17

3

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial

enthalten in: Circulation | 2023

von Chatur, S. | Vaduganathan, M. | Claggett, B. | +15

CommentIn: Circulation. 2023 Nov 28;148(22):1746-1749. - PMID 38011247

4

Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure : STEPping Across the Ejection Fraction Divide

enthalten in: Journal of the American College of Cardiology | 2023

von Vaduganathan, M. | Ostrominski, J.

CommentOn: J Am Coll Cardiol. 2023 Nov 28;82(22):2087-2096. - PMID 37993201

5

Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction : Insights from DELIVER

enthalten in: European journal of heart failure | 2023

von Butt, J. | Lu, H. | Kondo, T. | +10

CommentIn: Eur J Heart Fail. 2023 Nov;25(11):2091-2092. - PMID 37771264

6

Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

enthalten in: JACC. Heart failure | 2023

von Ostrominski, J. | Thierer, J. | Claggett, B. | +15

CommentIn: JACC Heart Fail. 2023 Nov;11(11):1504-1506. - PMID 37565975

7

Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease : A joint analysis of randomized controlled clinical trials

enthalten in: Diabetes, obesity & metabolism | 2023

von Heerspink, H. | Vart, P. | Jongs, N. | +10

8

Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function

enthalten in: Journal of the American College of Cardiology | 2023

von Chatur, S. | Vaduganathan, M. | Claggett, B. | +18

CommentIn: J Am Coll Cardiol. 2023 Nov 7;82(19):1864-1867. - PMID 37914516

9

Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

enthalten in: JAMA cardiology | 2023

von Ostrominski, J. | Arnold, S. | Butler, J. | +10

10

Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management

enthalten in: JAMA cardiology | 2023

von Bhatt, A. | Vaduganathan, M. | Claggett, B. | +9

CommentIn: JAMA Cardiol. 2023 Nov 1;8(11):1048-1049. - PMID 37755820

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]